Fourth-Quarter and Full-Year 2019 Orphan and Rheumatology Segment Results slide image

Fourth-Quarter and Full-Year 2019 Orphan and Rheumatology Segment Results

HORIZON KRYSTEXXA Our Biologic Medicine for Uncontrolled Gout with Significant Growth Potential 22
View entire presentation